NCT02984475
The Potential Hepatoprotective Effect of Metformin in Patients With Beta Thalassemia Major treatment 4 unknown_status NCT04962984
Thrombin Generation in Beta-thalassemia Major No drug interventions basic_science Not Available unknown_status NCT05693909
A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia treatment 2 recruiting NCT03948737
The Effect of Alpha-tocopherol in Hemolysis and Oxidative Stress Marker on the Red Cell Membrane Beta-thalassemia Major treatment Not Available completed NCT03591575
Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children treatment 4 completed NCT00000623
Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN) Not Available Not Available completed NCT04092205
Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation treatment 2 completed NCT00658385
Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major No drug interventions treatment Not Available completed NCT03947632
Anthropometric Measurements in Children Having Transfusion-dependent Beta Thalassemia No drug interventions Not Available Not Available completed NCT02744560
Effect of Spirulina on Liver Iron Concentration in Beta Thalassemic Children With Hepatitis C No drug interventions supportive_care Not Available completed NCT06466304
Inspiratory Muscle Training in Children With Beta Thalasemia No drug interventions treatment Not Available recruiting NCT03276455
Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified No drug interventions treatment 1 / 2 unknown_status NCT03101423
Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism treatment Not Available unknown_status NCT02173951
An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients treatment 2 / 3 unknown_status NCT02744547
Effect of Spirulina on Serum Hyaluronic Acid in Beta Thalassemic Children With Hepatitis C No drug interventions supportive_care Not Available completed NCT02744105
Effect of Spirulina on Liver Fibrosis by Transient Elastography in Beta Thalassemic Children With Hepatitis C No drug interventions supportive_care Not Available completed NCT02674607
the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children No drug interventions prevention Not Available completed NCT01571635
Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia. treatment 2 terminated NCT04353986
PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders treatment 3 recruiting NCT02671695
Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia treatment Not Available completed NCT04776850
Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies treatment 0 withdrawn NCT06596642
A Real-World Study of β-Thalassemia Major Treatment With Luspatercept in Taiwan Not Available Not Available recruiting NCT04205435
β-globin Restored Autologous HSC in β-thalassemia Major Patients No drug interventions treatment 1 / 2 terminated NCT01745120
A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in β-Thalassemia Major Participants No drug interventions treatment 1 / 2 completed NCT05776173
Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent β-thalassemia No drug interventions treatment Not Available recruiting NCT01724138
An Open Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of Deferasirox Administered to Chinese Patients With β-thalassemia Major Aged From 2 to Less Than 6 Years Old treatment 4 withdrawn NCT00390858
A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload. treatment 2 completed NCT01846923
B Memory Cell Response to Vaccination With the 13-valent Pneumococcal Conjugate Vaccine in Asplenic Individuals No drug interventions prevention 4 unknown_status NCT04592458
Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients No drug interventions treatment 1 not_yet_recruiting NCT04211480
Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells No drug interventions treatment Not Available completed NCT02342145
Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major prevention 4 unknown_status NCT06291961
A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major No drug interventions treatment 1 recruiting NCT00999349
Therapeutic Effects of Silymarin in Patients With B-thalassemia Major treatment 2 / 3 unknown_status NCT02151526
A Study Evaluating the Safety and Efficacy of LentiGlobin BB305 Drug Product in β-Thalassemia Major (Also Referred to as Transfusion-dependent β-Thalassemia [TDT]) and Sickle Cell Disease treatment 1 / 2 completed NCT03653338
T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias treatment 1 / 2 recruiting NCT01511848
Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload treatment 2 / 3 unknown_status NCT03040765
Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis treatment 3 terminated NCT02435901
HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity treatment 1 / 2 completed NCT00171301
Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration) treatment 4 completed NCT02198508
Clinical Trial of Deferasirox Combination Treatment With Deferiprone In Thalassaemia Patients treatment Not Available completed